Loading patent…
AssigneeZOLL Medical Corporation
InventorsGary A. Freeman, Ulrich Herken, Christopher L. Kaufman, Annemarie Elizabeth Silver
Estimating the term…
Embodiments of the present disclosure relate generally to the use of spectral sensors during a cardiac arrest event. More specifically, the present disclosure relates to the use of spectral sensors for measuring changes in pH and muscle oxygen saturation to estimate subject down time and evaluating the effectiveness of the clinical treatment administered during a cardiac arrest event. Given the narrow window of time in which emergency treatment must be administered, as well as the lack of information concerning the subject's condition, there is a need for a fast and accurate method of estimating the onset of the cardiac arrest emergency and evaluating the effectiveness of the emergency treatment being administered.
A patient monitoring system for assisting treatment of a patient experiencing a cardiac arrest event, the patient monitoring system comprising:
Dependencies are inferred from the claim text.